Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909799.0Aexternal-prioritypatent/GB9909799D0/en
Application filed by Gen Hospital Corp, Nycomed Imaging AsfiledCriticalGen Hospital Corp
Publication of AR021020A1publicationCriticalpatent/AR021020A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente caracteriza métodos de terapia de radiacion perfeccionada en base al descubrimiento del hecho que, usando combinaciones controladas de (i)composiciones radiodensas específicas, (ii) modos específicos de administracion de estas composiciones radiodensas y (iii) bandas de energía y fuentes deradiacion específicas, el efecto de radiacion sobre tumores y otros tejidos enfermos puede ser mejorado de manera efectiva y segura, para proporcionar unaterapia de radiacion significativamente perfeccionada.The present characterizes improved radiation therapy methods based on the discovery of the fact that, using controlled combinations of (i) specific radiodense compositions, (ii) specific modes of administration of these radiodense compositions and (iii) specific energy bands and radiation sources , the radiation effect on tumors and other diseased tissues can be effectively and safely improved, to provide a significantly improved radiation therapy.
ARP9901054691998-10-291999-10-29
RADIO MODE COMPOSITIONS
AR021020A1
(en)
A PHARMACEUTICAL COMPOSITION COMPRISING A DERIVATIVE OR ANALOGUE OF LEPTIN AS AN INHIBITOR OF THE PROLIFERATION OF TUMOR CELLS AND THE USE OF SUCH PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF MEDICINE FOR THE TREATMENT OF TUMORS